ABCL635

· AbCellera Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABCL635, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause [Phase 1, Phase 2]